News & Events about Cincor Pharma Inc.
NEW YORK, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CinCor Pharma, Inc. (NASDAQ: CINC)s sale to ...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - LBC, ALBO, CINC, LMST PR Newswire NEW YORK, Jan. 27, 2023 NEW YORK, Jan. 27, 2023 /PRNewswire...
NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased ...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of CinCor Pharma, Inc. (NasdaqGM: CINC) to AstraZeneca. Under the terms of the proposed transaction, shareholders of CinCor will receive...
Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm PR Newswire NEW YORK, Jan. 22, 2023 NEW YORK, Jan. 22, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation...